1. OS2.2 Highly personalized peptide vaccination for patients with newly diagnosed glioblastoma: the GAPVAC trial. (19th September 2018) Authors: Dietrich, P; Wick, W; Hilf, N; Frenzel, K; Gouttefangeas, C; Platten, M; thor Straten, P; Lassen, U; Rodon, J; Bukur, V; Admon, A; van der Burg, S H; von Deimling, A; Kroep, J R; Martinez-Ricarte, F; Okada, H; Ottensmeier, C H; Ponsati, B; Poulsen, H S; Stevanovic, S Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii219 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗